News & Insights

Medical device company transforming cardiac pacing and defibrillation lead technology, AtaCor Medical, announces its $28 million Series C financing.

Foresite Capital participates in Cullinan Therapeutics’ oversubscribed $280 million stock purchase agreement.

23 Gunderson Dettmer clients were recognized in Fast Company's 2024 World’s Most Innovative Companies list.

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP has elected six new partners, effective January 1. The elevations span the U.S. and add to the firm’s corporate and securities, venture and growth equity fund, public offerings/public companies, executive compensation and tax practices.